HR
ONCY

Howe & Rusling’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Howe & Rusling’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,000
Closed – – 1107
2015
Q4 		$0 Sell
1,000
-17
-2% -$7 ﹤0.01% 1147
2015
Q3 		$0 Hold
1,017
– – ﹤0.01% 1117
2015
Q2 		$1K Buy
1,017
+17
+2% +$12 ﹤0.01% 1033
2015
Q1 		$1K Hold
1,000
– – ﹤0.01% 921
2014
Q4 		$1K Hold
1,000
– – ﹤0.01% 893
2014
Q3 		$1K Hold
1,000
– – ﹤0.01% 878
2014
Q2 		$1K Hold
1,000
– – ﹤0.01% 797
2014
Q1 		$2K Hold
1,000
– – ﹤0.01% 787
2013
Q4 		$2K Hold
1,000
– – ﹤0.01% 719
2013
Q3 		$3K Hold
1,000
– – ﹤0.01% 772
2013
Q2 		$3K Buy
+1,000
New +$2.77K ﹤0.01% 793

Other funds holding ONCY

Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
KWMG
King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return

Howe & Rusling's ONCY Position: Q1 2016 in Review

Howe & Rusling sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2016, closing a stake of 1,000 shares.

Howe & Rusling first reported a position in ONCY in Q2 2013 and held it in 11 quarters. The position peaked at $3K in Q3 2013. 3 funds tracked by Wall St. Rank hold ONCY as of Q1 2016.

  • Howe & Rusling reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2016 after selling out during the quarter.
  • Howe & Rusling sold 1,000 ONCOLYTICS BIOTECH INC shares in Q1 2016.
  • Howe & Rusling first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 11 quarters.
  • Howe & Rusling's ONCOLYTICS BIOTECH INC position peaked at $3K in Q3 2013.
  • 3 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2016.

Based on Howe & Rusling's 13F filing for Q1 2016, filed 16 May 2016.